Cardiometabolic disorders and menopausal hormone therapy
The review highlights the role of endo- and exogenous estrogens and androgens in the genesis of cardiometabolic disorders in postmenopausal women and the role of menopausal hormone therapy in their prevention.
Saved in:
Main Authors: | V Ye Balan (Author), L M Ilina (Author), E V Tikhomirova (Author), A V Tsarkova (Author), I N Lazareva (Author), D V Grigorieva (Author) |
---|---|
Format: | Book |
Published: |
IP Berlin A.V.,
2017-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
New trends in current menopausal hormone therapy
by: Vera E. Balan, et al.
Published: (2021) -
Menopausal metabolic syndrome and the risks of menopausal hormone therapy: the solutions
by: A.E. Esedova, et al.
Published: (2020) -
Menopausal hormone therapy: a course to improve the effectiveness
by: A L Unanyan, et al.
Published: (2017) -
The choice of hormonal and alternative therapy in menopausal and post-menopausal period
by: Kuznetsova I.V
Published: (2018) -
Individual choice of menopausal hormone therapy
by: T V Ovsyannikova, et al.
Published: (2016)